Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
Ahmad Al-Ghazawi, PhD
Advertisement
Articles by Ahmad Al-Ghazawi, PhD
Advertisement
Latest Updated Articles
Gastric-State-Controlled Bioequivalence StudiesPublished: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Futureproofing Viral Safety: Global Perspectives from an Educator, Supplier, and Biosafety Expert
4
